Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination

scientific article published on 9 August 2002

Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/342559
P698PubMed publication ID12195350
P5875ResearchGate publication ID11193599

P50authorJohn M. MurrayQ41046114
Viviana SimonQ54435264
Alan S. PerelsonQ55719625
Jeroen VanderhoevenQ57015306
P2093author name stringBharat Ramratnam
Arlene Hurley
Martin Markowitz
Tian He
David D Ho
Linqi Zhang
Xia Jin
Michael Louie
Chris Chung
Murugappan Ramanathan
Geoffrey R Deschenes
Shady Barsoum
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)634-643
P577publication date2002-08-09
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleDiscontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination
P478volume186

Reverse relations

cites work (P2860)
Q27319650A tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessation
Q34047774AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein
Q35729054Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.
Q36099376Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection
Q40519226Advances in the diagnosis and treatment of acute human immunodeficiency virus type 1 (HIV-1) infection
Q36223710Advances in understanding immunologic control of HIV infection
Q51971392An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.
Q35784804Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load
Q36198648Clinical experience with therapeutic AIDS vaccines
Q34550802Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL.
Q28472597Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood
Q28554534DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus
Q36474240Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2
Q28742727Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption
Q26777442Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions
Q33941340Features of responding T cells in cancer and chronic infection.
Q34567084Finding a cure for HIV: will it ever be achievable?
Q38101294From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication
Q40478109HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.
Q43130032HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.
Q33731771HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound
Q33745356Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption
Q34351326Immune interventions in HIV infection
Q28183667Immunopathogenesis and immunotherapy in AIDS virus infections
Q34779237Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort
Q24804986Limited durability of viral control following treated acute HIV infection
Q35635412Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization
Q37365718Modeling HIV persistence, the latent reservoir, and viral blips
Q38692205New challenges in therapeutic vaccines against HIV infection.
Q34220902No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial
Q38915896Novel immunological strategies for HIV-1 eradication
Q24799820Optimal clinical trial designs for immune-based therapies in persistent viral infections
Q75300535Primary HIV Infection
Q81433335Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment
Q36223861Primary human immunodeficiency virus type 1 infection
Q73733752Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251
Q33698152Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
Q33332291Resisting immune exhaustion in HIV-1 infection.
Q46856608Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection
Q35108735Supervised interruptions of antiretroviral therapy
Q33586581The detection and management of early HIV infection: a clinical and public health emergency
Q36223826Therapeutic HIV vaccines: an update
Q36238709Therapeutic immunization strategies for the control of HIV-1.
Q36846254Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire
Q94923880Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
Q38013505Therapeutic vaccines against HIV infection
Q35140817Therapeutic vaccines against HIV need international partnerships
Q38626469Toward a cure for HIV--Seeking effective therapeutic vaccine strategies
Q36280900Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort
Q38209874Update on antiretroviral treatment during primary HIV infection
Q34409178Vaccines: past, present and future

Search more.